CancerDrs Find care

Testicular Cancer clinical trials in California

14 actively recruiting testicular cancer trials at 41 sites across California.

Data from ClinicalTrials.gov · last refreshed

Phase 3 Recruiting Network

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it dev…

Sponsor: Children's Oncology Group
NCT ID: NCT03067181
Sites in California:
  • Kaiser Permanente-Anaheim — Anaheim, California
  • Mission Hope Medical Oncology - Arroyo Grande — Arroyo Grande, California
  • PCR Oncology — Arroyo Grande, California
  • Kaiser Permanente-Bellflower — Bellflower, California
  • Providence Saint Joseph Medical Center/Disney Family Cancer Center — Burbank, California
Phase 3 Recruiting Network

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy and immunotherapy (chemo-immunotherapy) for patients with High-Risk B-cell Acute Lymphoblastic Leukemia (B-ALL) improves outcomes. Inotuzumab o…

Sponsor: Children's Oncology Group
NCT ID: NCT03959085
Sites in California:
  • Kaiser Permanente Downey Medical Center — Downey, California
  • City of Hope Comprehensive Cancer Center — Duarte, California
  • Loma Linda University Medical Center — Loma Linda, California
  • Miller Children's and Women's Hospital Long Beach — Long Beach, California
  • Children's Hospital Los Angeles — Los Angeles, California
Phase 2 Recruiting NIH

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from where it first started (primary site) to other places in the…

Sponsor: National Cancer Institute (NCI)
NCT ID: NCT03866382
Sites in California:
  • Mission Hope Medical Oncology - Arroyo Grande — Arroyo Grande, California
  • PCR Oncology — Arroyo Grande, California
  • Providence Saint Joseph Medical Center/Disney Family Cancer Center — Burbank, California
  • Community Cancer Institute — Clovis, California
  • University Oncology Associates — Clovis, California
Phase 1 Recruiting Industry

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

The primary purpose of this study is to determine whether the investigational drug XmAb541 is safe and well tolerated, and to determine an optimal and safe dose(s) for further study. The study will also evaluate the effect of XmAb541 on tu…

Sponsor: Xencor, Inc.
NCT ID: NCT06276491
Sites in California:
  • City of Hope — Duarte, California
  • Stanford — Palo Alto, California
  • University of California — San Francisco, California
Phase 1 Recruiting Industry

A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors

This is a Phase 1a/1b, open-label, dose escalation and expansion study to evaluate the safety and efficacy of CTIM-76 (study drug), a CLDN6-directed T cell-engaging bispecific antibody, in participants with platinum-refractory/resistant ov…

Sponsor: Context Therapeutics Inc.
NCT ID: NCT06515613
Sites in California:
  • Precision NextGen Oncology & Research Center — Beverly Hills, California
Phase 1 Recruiting Academic/Other

Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors

This phase I trial evaluates whether adding Pedmark to standard of care cisplatin-based chemotherapy reduces drug-induced ear damage (ototoxicity) in men with stage II-III testicular germ cell tumors that have spread from where they first …

Sponsor: City of Hope Medical Center
NCT ID: NCT07218913
Sites in California:
  • City of Hope Medical Center — Duarte, California
Phase 1 Recruiting Academic/Other

Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers

This phase I trial is evaluating a new imaging tracer (68Ga-FAPi-46) with positron emission tomography (PET)/computed tomography (CT) to determine where and to which degree the tracer (68Ga-FAPi-46) accumulates in normal and cancer tissues…

Sponsor: Jonsson Comprehensive Cancer Center
NCT ID: NCT07118176
Sites in California:
  • UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California
NA Recruiting Network

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

The purpose of this study is to evaluate feasibility and acceptability of completing PROs among AYAs randomized to Choice PRO vs Fixed PRO.

Sponsor: Eastern Cooperative Oncology Group
NCT ID: NCT05108298
Sites in California:
  • Mission Hope Medical Oncology - Arroyo Grande — Arroyo Grande, California
  • PCR Oncology — Arroyo Grande, California
  • Mercy Cancer Center - Carmichael — Carmichael, California
  • Mercy San Juan Medical Center — Carmichael, California
  • Epic Care-Dublin — Dublin, California
Recruiting Industry

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinic…

Sponsor: Massive Bio, Inc.
NCT ID: NCT03452774
Sites in California:
  • Massive Bio SYNERGY-AI site — Duarte, California
  • Massive Bio SYNERGY-AI site — Irvine, California
  • Massive Bio SYNERGY-AI site — La Jolla, California
  • Massive Bio SYNERGY-AI site — Orange, California
  • Massive Bio SYNERGY-AI site — San Francisco, California
Recruiting Industry

DESTINY-PANTUMOUR04

This study will evaluate the effectiveness of T-DXd in patients with HER2-positive (IHC 3+) locally advanced, unresectable, or metastatic solid tumors who have received prior systemic treatment for metastatic or advanced disease and have n…

Sponsor: AstraZeneca
NCT ID: NCT07124000
Sites in California:
  • Research Site — San Diego, California
Recruiting Academic/Other

MAGESTIC Trial: MiRNA in Detecting Active Germ Cell Tumors in Early Suspected and MetastaTIC Disease Trial

This study evaluates the accuracy of blood-based biomarker testing to predict the presence of active testicular cancer.

Sponsor: University of Southern California
NCT ID: NCT06060873
Sites in California:
  • Loma Linda University Medical Center — Loma Linda, California
  • Los Angeles County-USC Medical Center — Los Angeles, California
  • USC / Norris Comprehensive Cancer Center — Los Angeles, California
Recruiting Academic/Other

Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors

This study assesses how personal relationships (such as friendships, family relationships, or romantic partners) influence the physical activity (exercise) and well-being of young adult cancer survivors. Researchers also hope to learn how …

Sponsor: University of Southern California
NCT ID: NCT07259304
Sites in California:
  • USC / Norris Comprehensive Cancer Center — Los Angeles, California
NA Recruiting Academic/Other

A Biobehavioral Intervention to Reduce Adverse Outcomes in Young Adult Testicular Cancer Survivors

This study is a randomized controlled biobehavioral efficacy trial designed to investigate the feasibility and acceptability of a novel intervention, Goal-focused Emotion-Regulation Therapy (GET) aimed at improving distress symptoms, emoti…

Sponsor: University of California, Irvine
NCT ID: NCT05836688
Sites in California:
  • University of California, Irvine — Irvine, California
NA Recruiting Academic/Other

Patient Reported Experiences With Sparing External Oblique Fascia Vs Standard Inguinal Orchiectomy

The purpose of this study is to evaluate the difference in patient-reported postoperative outcomes between two standard-of-care surgical techniques for radical orchiectomy (inguinal orchiectomy versus external oblique fascia sparing orchie…

Sponsor: Loma Linda University
NCT ID: NCT06828185
Sites in California:
  • Loma Linda University — Loma Linda, California

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-04-20